Company Description
Canton Strategic Holdings, Inc. focuses on advancing institutional blockchain adoption and digitizing financial markets in the United States.
The company operates as a validator and super validator on the Canton Network, which provides validation and liveness services to the network.
It also provides locking-as-a-service (LaaS) to Canton Network super validators and featured applications, which locks its own Canton Coin (CC) on a customer's behalf while retaining legal and beneficial ownership.
In addition, the company invests in the Canton ecosystem. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026.
Canton Strategic Holdings, Inc. was incorporated in 2017 and is based in New York, New York.
| Country | United States |
| Founded | 2017 |
| IPO Date | Jan 12, 2022 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 12 |
| CEO | Mark Wendland |
Contact Details
Address: 1460 Broadway New York, New York 10036 United States | |
| Phone | 212 210 6006 |
| Website | cantonstrategic.com |
Stock Details
| Ticker Symbol | CNTN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1861657 |
| CUSIP Number | 432705309 |
| ISIN Number | US4327053090 |
| Employer ID | 84-2642541 |
| SIC Code | 6199 |
Key Executives
| Name | Position |
|---|---|
| Mark Wendland | Chief Executive Officer and Chairman of the Board |
| Mark Toomey | President |
| Jacob Asbury | Chief Financial Officer |
| Angela Dominy Radkowski | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Jul 23, 2026 | 8-K | Current Report |
| Jul 17, 2026 | 8-K | Current Report |
| Jul 8, 2026 | SCHEDULE 13G/A | Filing |
| Jun 25, 2026 | DEF 14A | Other definitive proxy statements |
| Jun 16, 2026 | 8-K | Current Report |
| May 13, 2026 | 10-Q | Quarterly Report |
| May 11, 2026 | SCHEDULE 13G/A | Filing |
| Apr 15, 2026 | D | Notice of Exempt Offering of Securities |